Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Physical Exercise During Neoadjuvant Chemotherapy for Breast Cancer as a Means to Increase Pathological Complete Response Rates: the Randomized Neo-ACT Trial

NCT05184582 is registered in ClinicalTrials.gov with Karolinska Institutet as lead sponsor.

NCT NCT05184582
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05184582 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Physical Exercise During Neoadjuvant Chemotherapy for Breast Cancer as a Means to Increase Pathological Complete Response Rates: the Randomized Neo-ACT Trial
Lead sponsor
Karolinska Institutet
Phase
Not applicable
Overall status
Recruiting
Start date
November 9, 2022
Completion date
June 30, 2028
Enrollment
712 (estimated)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer